Tuesday, August 15, 2017 -- Not only is Zika still a potential danger, but its capacity to spread in the United States could be greater than anticipated. The post Is Zika Still a Threat? The CDC Says Yes. appeared first on Quest Diagnostics Blog.
Tuesday, August 15, 2017 -- The less-costly tobacco-plant derived vaccine will be targeted for the developing world.
Monday, August 14, 2017 -- Lisa Schnirring | News Editor | CIDRAP NewsAug 14, 2017The patients, hospitalized at a speciality center, had a variety of complications and some unusual features.
Thursday, August 17, 2017 -- The FDA has just announced that it has made a panel of human plasma samples available to assist in evaluation of serological tests to detect recent Zika virus infection.
Monday, August 14, 2017 -- The Center for Infection and Immunity at Columbia University's Mailman School today announced that the U.S. Food and Drug Administration has issued an Emergency Use Authorization for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Thursday, August 17, 2017 -- West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone now?
Tuesday, August 15, 2017 -- Zika virus infection was associated with an increase in the incidence of serious neurologic syndromes among a cohort of Brazilian adults, in a new study published in JAMA Neurology.
Monday, August 14, 2017 -- Some vaccine developers are taking steps to include them, in line with bioethicists' urging, but it will likely take years before any expectant mothers are enrolled.
Thursday, August 17, 2017 -- But smaller future outbreaks are likely, scientists warn
Tuesday, August 15, 2017 -- Increase in admissions for Guillain-Barré syndrome, encephalitis compared with before outbreak
Tuesday, August 15, 2017 -- The FDA has authorized the ArboViroPlex rRT-PCR Test — a multiplex assay that can simultaneously test for Zika virus, all dengue virus serotypes, chikungunya virus and West Nile virus — for emergency use.Developed by scientists at the Center for Infection and Immunity at Columbia University’s Mailman School of Public Health, this multiplex test is intended for use in the Zika in Infants and Pregnancy study, an international study launched by the National Institutes of Health to examine the health risks that Zika virus poses to pregnant women and their infants.
Tuesday, August 15, 2017 -- Zika is often a silent disease that might not display any symptoms in infected persons, making screening particularly important. In the developing world, mobile testing systems that can be easily transported and used are not available, so sending a sample to a lab is still required to detect Zika infected individuals. Researchers at Washington University […]